Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBDermis: Phytocannabinoids for Psoriasis Vulgaris
NCT07839455Phase 2Active, not recruiting
- Sponsor
- Federal University of Latin American Integration
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of VER-01 in Psoriasis vulgaris (PV), sponsored by Federal University of Latin American Integration. Started Nov 2025; status: active, not recruiting.
02
Drugs
VER-01
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT07839455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839455.